Baseline Clinical Factors Associated with Cessation of Growth Hormone Therapy in Patients with Severe Growth Hormone Deficiency - Real World Evidence
In this real-world investigation of patients with severe GH deficiency, over two in five individuals who discontinued GH therapy cited the absence of perceived benefits. We show a borderline association of female gender with GH cessation and large population-based studies will be needed to investigate this and other causes of GH cessation.
Authors
- Kazeem Adeleke (ORCID: https://orcid.org/0000-0002-3854-9678)
- Thozhukat Sathyapalan (ORCID: https://orcid.org/0000-0003-3544-2231)
- Harshal Deshmukh (ORCID: https://orcid.org/0000-0002-3859-3118)
- Emmanuel Ssemmondo (ORCID: https://orcid.org/0000-0002-2796-5027)
- Remi Akinyombo
- Shani Brooks
- Nageswary Nadarajah
Institutions
- University of Hull (GB)
- University of Cambridge (GB)
Publication Details
- Journal
- International Journal of Endocrinology and Metabolism
- Published
- 2024-10-27
- DOI
- https://doi.org/10.5812/ijem-147825
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00